Cited by 342Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingNeurological diseases and metabolism

The DOI matches its Crossref record; 46 of the 49 references it cites were found in a registry or an index.

PINK1 protein in normal human brain and Parkinson's disease

Gandhi, S.·2006·Brain

DOI 10.1093/brain/awl114

Open this paper in CoChat — free account

Abstract

Parkinson's disease is a common incurable neurodegenerative disease whose molecular aetiology remains unclear. The identification of Mendelian genes causing rare familial forms of Parkinson's disease has revealed novel proteins and pathways that are likely to be relevant in the pathogenesis of sporadic Parkinson's disease. Recently, mutations in a novel gene, PINK1, encoding a 581 amino acid protein with both mitochondrial targeting and serine/threonine kinase domains, were identified as a cause of autosomal recessive parkinsonism. This provided important evidence for the role of the mitochondrial dysfunction and kinase pathways in neurodegeneration. In this study, we report the first characterization of the PINK1 protein in normal human and sporadic Parkinson's brains, in addition to Parkinson's cases with heterozygous PINK1 mutations. The possible role of the PINK1 protein was also assessed in a number of neurodegenerative diseases characterized by proteinaceous inclusions. For these studies, rabbit polyclonal antibodies were raised against two peptide sequences within the N-terminal hydrophilic loops of PINK1 protein. Using immunohistochemistry and western blotting we were able to demonstrate that PINK1 is a ubiquitous protein expressed throughout the human brain and it is found in all cell types showing a punctate cytoplasmic staining pattern consistent with mitochondrial localization. Fractionation studies of human and rat brain confirm that PINK1 is localized to the mit…

Integrity signals

Registry

Crossref · 10.1093/brain/awl114

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
α-Synuclein in Lewy bodies
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854

Show all 49 references

Sorted by citations

Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S., & Chesselet, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 953
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 798
Parkinson's disease
Thomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748
Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin
Ziviani, E., Tao, R. N., & Whitworth, A. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913485107 · Cited by 735
Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
Gautier, C. A., Kitada, T., & Shen, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802076105 · Cited by 698
Mitochondrial dysfunction in Parkinson's disease
Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688
The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila
Deng, H., Dodson, M. W., Huang, H., & Guo, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803998105 · Cited by 707
PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death
Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D. S., Tabrizi, S. J., Wood, N. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.013 · Cited by 682
Self-citation
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 652
PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1
Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050172 · Cited by 596
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
Tansey, M. G., McCoy, M. K., & Frank-Cannon, T. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.004 · Cited by 587
The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates
Wakabayashi, K., Tanji, K., Mori, F., & Takahashi, H. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00803.x · Cited by 544
Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin
Exner, N., Treske, B., Paquet, D., Holmström, K. M., Schiesling, C., Gispert, S., Carballo‐Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0719-07.2007 · Cited by 523
PINK1 cleavage at position A103 by the mitochondrial protease PARL
Deas, E., Plun‐Favreau, H., Gandhi, S., Desmond, H., Kjaer, S., Loh, S. H. Y., Renton, A. E., Harvey, R. J., Whitworth, A. J., Martins, L. M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq526 · Cited by 501
Self-citation
The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders
Wakabayashi, K., Tanji, K., Odagiri, S., Miki, Y., Mori, F., & Takahashi, H. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8280-y · Cited by 507
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1
Plun‐Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., Harvey, K., Deas, E., Harvey, R. J., McDonald, N. Q., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1644 · Cited by 476
Self-citation
Glia: Initiators and progressors of pathology in Parkinson's disease
Halliday, G. M., & Stevens, C. H. (2011) · Movement Disorders · doi:10.1002/mds.23455 · Cited by 436
Mitochondrial Diseases of the Brain
Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 426
Histone deacetylase 6 interacts with the microtubule‐associated protein tau
Ding, H., Dolan, P. J., & Johnson, G. V. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05564.x · Cited by 387
The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking
Meißner, C., Lorenz, H., Weihofen, A., Selkoe, D. J., & Lemberg, M. K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07253.x · Cited by 395
Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation
Norat, P., Soldozy, S., Sokolowski, J. D., Gorick, C. M., Kumar, J. S., Chae, Y., Yağmurlu, K., Prada, F. U., Walker, M., Levitt, M. R., et al. (2020) · npj Regenerative Medicine · doi:10.1038/s41536-020-00107-x · Cited by 366
Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature
Schneider, S. A., & Alcalay, R. N. (2017) · Movement Disorders · doi:10.1002/mds.27193 · Cited by 355
Understanding the molecular causes of Parkinson's disease
Wood‐Kaczmar, A., Gandhi, S., & Wood, N. W. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.09.007 · Cited by 334
Self-citation
PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons
Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A. S. Y., Miljan, E. A., Keen, G., Stanyer, L., Hargreaves, I., Klupsch, K., Deas, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002455 · Cited by 316
Self-citation
The kinase domain of mitochondrial PINK1 faces the cytoplasm
Zhou, C. H., Huang, Y., Shao, Y., May, J., Prou, D., Perier, C., Dauer, W. T., Schon, E. A., & Przedborski, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802814105 · Cited by 319
The Genetics of Parkinson Disease
Bekris, L. M., Mata, I. F., & Zabetian, C. P. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383572 · Cited by 314
The neuropathology of genetic Parkinson's disease
Poulopoulos, M., Levy, O. A., & Alcalay, R. N. (2012) · Movement Disorders · doi:10.1002/mds.24962 · Cited by 315
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
Klein, C., Lohmann-Hedrich, K., Rogaeva, E. A., Schlossmacher, M. G., & Lang, A. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70174-6 · Cited by 309
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288
Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease
Dodson, M. W., & Guo, M. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.04.010 · Cited by 281
Characterization of PINK1 processing, stability, and subcellular localization
Lin, W., & Kang, U. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05398.x · Cited by 269
PINK1-linked parkinsonism is associated with Lewy body pathology
Samaranch, L., Lorenzo‐Betancor, O., Arbelo, J. M., Ferrer, I., Lorenzo, E., Irigoyen, J., Pastor, M. A., Marrero, C., Isla, C., Herrera-Henriquez, J., et al. (2010) · Brain · doi:10.1093/brain/awq051 · Cited by 256
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
Banerjee, R., Starkov, A. A., Beal, M. F., & Thomas, B. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.007 · Cited by 262
Impairing the Mitochondrial Fission and Fusion Balance: A New Mechanism of Neurodegeneration
Knott, A. B., & Bossy‐Wetzel, E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.030 · Cited by 263
Degeneration in Different Parkinsonian Syndromes Relates to Astrocyte Type and Astrocyte Protein Expression
Song, Y. J. C., Halliday, G. M., Holton, J. L., Lashley, T., O’Sullivan, S. S., McCann, H., Lees, A. J., Ozawa, T., Williams, D. R., Lockhart, P. J., et al. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b66f1b · Cited by 245
Pathogenic mutations in Parkinson disease
Tan, E., & Skipper, L. M. (2007) · Human Mutation · doi:10.1002/humu.20507 · Cited by 224
The genetics of Parkinson's syndromes: a critical review
Hardy, J., Lewis, P. A., Révész, T., Lees, A. J., & Paisán‐Ruiz, C. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.03.008 · Cited by 216
Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder
Klein, C., & Schlossmacher, M. G. (2007) · Neurology · doi:10.1212/01.wnl.0000271880.27321.a7 · Cited by 212
Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6
Hoepken, H.-H., Gispert, S., Morales, B., Wingerter, O., Turco, D. D., Mülsch, A., Nussbaum, R. L., Müller, K., Dröse, S., Brandt, U., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.007 · Cited by 205
Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC Cells
Gegg, M. E., Cooper, J. M., Schapira, A. H. V., & Taanman, J.-W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004756 · Cited by 198
Antioxidants protect PINK1 -dependent dopaminergic neurons in Drosophila
Wang, D., Li, Q., Xiong, H., Liu, J., Neckameyer, W. S., Oldham, S., Xia, K., Wang, J., Bodmer, R., & Zhang, Z. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604661103 · Cited by 203
The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease
Zuo, L., & Motherwell, M. S. (2013) · Gene · doi:10.1016/j.gene.2013.07.085 · Cited by 200
Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth
Sämann, J., Hegermann, J., von Gromoff, E. D., Eimer, S., Baumeister, R., & Schmidt, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808255200 · Cited by 199
Mitochondrial DNA damage and repair in neurodegenerative disorders
Yang, J., Weissman, L., Bohr, V. A., & Mattson, M. P. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.03.012 · Cited by 187
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
Tran, J., Anastacio, H. T. D., & Bardy, C. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-0110-8 · Cited by 190
Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF- B signaling
Sha, D., Chin, L., & Li, L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp501 · Cited by 187
Loss of PINK1 Function Affects Development and Results in Neurodegeneration in Zebrafish
Anichtchik, O. V., Diekmann, H., Fleming, A., Roach, A. G., Goldsmith, P., & Rubinsztein, D. C. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0979-08.2008 · Cited by 184
Mitochondrial Dysfunction in Parkinson's Disease
Keane, P. C., Kurzawa‐Akanbi, M., Blain, P. G., & Morris, C. M. (2011) · Parkinson s Disease · doi:10.4061/2011/716871 · Cited by 182
A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases
Mandemakers, W. J., Morais, V. A., & Strooper, B. D. (2007) · Journal of Cell Science · doi:10.1242/jcs.03443 · Cited by 183
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress
Muqit, M. M. K., Abou‐Sleiman, P. M., Saurin, A. T., Harvey, K., Gandhi, S., Deas, E., Eaton, S. D., Smith, M. D. P., Venner, K., Matilla‐Dueñas, A., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03845.x · Cited by 172
Self-citation
Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease
Shi, G. W., Lee, J. R., Grimes, D. A., Racacho, L., Ye, D., Yang, H. H., Ross, O. A., Farrer, M. J., McQuibban, G. A., & Bulman, D. E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr077 · Cited by 173
Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1
Weihofen, A., Ostaszewski, B. L., Minami, Y., & Selkoe, D. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm334 · Cited by 169
A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease
Chu, C. T. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq143 · Cited by 177
Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse
Perfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.042 · Cited by 169
miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1)
Kim, J., Fiesel, F. C., Belmonte, K. C., Hudec, R., Wang, W.-X., Kim, C., Nelson, P. T., Springer, W., & Kim, J. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0121-4 · Cited by 163
“PINK1 is expressed ubiquitously in neurons throughout the human brain [59, 60].”
Background
Astrocytic Oxidative/Nitrosative Stress Contributes to Parkinson’s Disease Pathogenesis: The Dual Role of Reactive Astrocytes
Rizor, A., Pajarillo, E. A. B., Johnson, J., Aschner, M., & Lee, E.-S. (2019) · Antioxidants · doi:10.3390/antiox8080265 · Cited by 165
Genetic basis of Parkinson's disease: inheritance, penetrance, and expression
Gasser, T. (2011) · The Application of Clinical Genetics · doi:10.2147/tacg.s11639 · Cited by 169
PINK1 function in health and disease
Deas, E., Plun‐Favreau, H., & Wood, N. W. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900024 · Cited by 154
C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1
Sim, C. H., Lio, D. S. S., Mok, S. S., Masters, C. L., Hill, A. F., Culvenor, J. G., & Cheng, H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl398 · Cited by 147
The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson’s Disease
Lin, K.-J., Lin, K.-L., Chen, S., Liou, C., Chuang, Y., Lin, H., & Lin, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215312 · Cited by 141
The role of mitochondria in neurodegenerative diseases
Filosto, M., Scarpelli, M., Cotelli, M. S., Vielmi, V., Todeschini, A., Gregorelli, V., Tonin, P., Tomelleri, G., & Padovani, A. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6104-z · Cited by 142
Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
Chaturvedi, R. K., & Beal, M. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.011 · Cited by 139
Mitochondrial dynamics in Parkinson's disease
Laar, V. S. V., & Berman, S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.019 · Cited by 141
The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function
Schéele, C., Petrovič, N., Faghihi, M. A., Lassmann, T., Fredriksson, K., Rooyackers, O., Wahlestedt, C., Good, L., & Timmons, J. A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-74 · Cited by 138
The PINK1/Parkin pathway: a mitochondrial quality control system?
Whitworth, A. J., & Pallanck, L. J. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9253-3 · Cited by 137
Review: Familial Parkinson's disease – genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease
Schiesling, C., Kieper, N., Seidel, K., & Krüger, R. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00952.x · Cited by 143
Mitochondrial alterations in Parkinson’s disease: new clues
Vila, M., Ramonet, D., & Perier, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05604.x · Cited by 131
Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration
Croisier, E., & Graeber, M. B. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0119-z · Cited by 132
PINK1-Parkin Pathway Activity Is Regulated by Degradation of PINK1 in the Mitochondrial Matrix
Thomas, R. E., Andrews, L. A., Burman, J. L., Lin, W.-Y., & Pallanck, L. J. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004279 · Cited by 134
Unconventional PINK1 localization mechanism to the outer membrane of depolarized mitochondria drives Parkin recruitment
Okatsu, K., Kimura, M., Oka, T., Tanaka, K., & Matsuda, N. (2015) · Journal of Cell Science · doi:10.1242/jcs.161000 · Cited by 133
PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons
Wang, H., Chou, A.-H., Wu, A.-S., Chen, S.-Y., Weng, Y.-H., Kao, Y.-C., Yeh, T., Chu, P., & Lu, C.-S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.007 · Cited by 122
Beyond the mitochondrion: cytosolic PINK 1 remodels dendrites through Protein Kinase A
Dagda, R. K., Pien, I., Wang, R., Zhu, J., Wang, K. Z. Q., Callio, J., Banerjee, T. D., Dagda, R. Y., & Chu, C. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12494 · Cited by 122
Calcium signaling in Parkinson’s disease
Calí, T., Ottolini, D., & Brini, M. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1866-0 · Cited by 124
Molecular Pathology of Lewy Body Diseases
Beyer, K., Domingo-Sàbat, M., & Ariza, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10030724 · Cited by 127
Autophagy-related proteins are functionally active in human spermatozoa and may be involved in the regulation of cell survival and motility
Aparicio, I. M., Espino, J., Bejarano, I., Gallardo, A., Campo, M. L., Salido, G. M., Pariente, J. A., Peña, F. J., & Tapia, J. A. (2016) · Scientific Reports · doi:10.1038/srep33647 · Cited by 121
Protein Misfolding and Aggregation in Parkinson's Disease
Tan, J. M. M., Wong, E. S. P., & Lim, K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2490 · Cited by 121
Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1
Takatori, S., Ito, G., & Iwatsubo, T. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.10.019 · Cited by 119
Etiology and Pathogenesis of Parkinson Disease
Schapira, A. H. V. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.04.004 · Cited by 120
Kinases and kinase signaling pathways: Potential therapeutic targets in Parkinson's disease
Wang, G., Pan, J., & Chen, S. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.003 · Cited by 117
A critical evaluation of the ubiquitin–proteasome system in Parkinson's disease
Cook, C. N., & Petrucelli, L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.012 · Cited by 119
Mitochondria Dysfunction and Neurodegenerative Disorders: Cause or Consequence
Morais, V. A., & Strooper, B. D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100345 · Cited by 111
Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?
Scheele, C., Nielsen, A. R., Walden, T. B., Sewell, D. A., Fischer, C. P., Brogan, R. J., Petrovic, N., Larsson, O., Tesch, P. A., Wennmalm, K., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8520com · Cited by 110
Impact of recent genetic findings in Parkinson??s disease
Klein, C., & Lohmann-Hedrich, K. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3281e6692b · Cited by 113
Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse
Perfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.569 · Cited by 109
Mitochondrial Respiratory Dysfunction in Familiar Parkinsonism Associated with PINK1 Mutation
Piccoli, C., Sardanelli, A. M., Scrima, R., Ripoli, M. C., Quarato, G., D’Aprile, A., Bellomo, F., Scacco, S., Michele, G. D., Filla, A., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9729-2 · Cited by 109
Pathological Functions of LRRK2 in Parkinson’s Disease
Jeong, G. R., & Lee, B. D. (2020) · Cells · doi:10.3390/cells9122565 · Cited by 110
Reduction of Protein Translation and Activation of Autophagy Protect against PINK1 Pathogenesis in Drosophila melanogaster
Liu, S., & Lu, B. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001237 · Cited by 105
DJ-1 facilitates the interaction between STAT1 and its phosphatase, SHP-1, in brain microglia and astrocytes: A novel anti-inflammatory function of DJ-1
Kim, J.-H., Choi, D.-J., Jeong, H.-K., Kim, J., Kim, D. W., Choi, S. Y., Park, S.-M., Suh, Y. H., Jou, I., & Joe, E.-H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.08.007 · Cited by 102
Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease
Hatano, T., Kubo, S., Sato, S., & Hattori, N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06403.x · Cited by 100
The roles of non-coding RNAs in Parkinson’s disease
Majidinia, M., Mihanfar, A., Rahbarghazi‬, R., Nourazarian, A., Bağca, B. G., & Avcı, Ç. B. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-4054-3 · Cited by 96
Parallel High-Throughput RNA Interference Screens Identify PINK1 as a Potential Therapeutic Target for the Treatment of DNA Mismatch Repair–Deficient Cancers
Martin, S. A., Hewish, M., Sims, D., Lord, C. J., & Ashworth, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2836 · Cited by 96
Biochemical aspects of the neuroprotective mechanism of PTEN‐induced kinase‐1 (PINK1)
Mills, R. D., Sim, C. H., Mok, S. S., Mulhern, T. D., Culvenor, J. G., & Cheng, H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05249.x · Cited by 95
Early Expression of Parkinson’s Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats
Villeneuve, L. M., Purnell, P. R., Boska, M. D., & Fox, H. S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8927-y · Cited by 92
Pink1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced akt and increased p38 mapk activation, and downregulation of egfr
Choi, I., Kim, J., Jeong, H., Kim, B., Jou, I., Park, S. M., Chen, L.-N., Kang, U. J., Zhuang, X., & Joe, E.-H. (2013) · Glia · doi:10.1002/glia.22475 · Cited by 90
TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency
Flinn, L. J., Keatinge, M., Bretaud, S., Mortiboys, H., Matsui, H., Felice, E. D., Woodroof, H. I., Brown, L., McTighe, A., Soellner, R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23999 · Cited by 88
Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish
Sallinen, V. J., Kolehmainen, J., Priyadarshini, M., Toleikyte, G., Chen, Y., & Panula, P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.001 · Cited by 91
PINK1 mutants associated with recessive Parkinson’s disease are defective in inhibiting mitochondrial release of cytochrome c
Wang, H., Chou, A.-H., Yeh, T., Li, A. H.-L., Chen, Y., Kuo, Y.-L., Tsai, S.-R., & Yu, S.-T. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.010 · Cited by 90
Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?
Bogaerts, V., Theuns, J., & Broeckhoven, C. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 91
Mitochondrial dynamics, cell death and the pathogenesis of Parkinson’s disease
Büeler, H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0465-0 · Cited by 87

Authors: Gandhi, S.
Affiliations: UCL Queen Square Institute of Neurology (GB)
Corresponding author: Gandhi, S.
ORCID: Gandhi, S.
Venue: Brain
Publisher: Oxford University Press (OUP)
Published: 2006-07-01
Volume: 129
Issue: 7
Pages: 1720-1731
ISSN: 0006-8950 (ISSN-L)
1460-2156
DOI: 10.1093/brain/awl114
OpenAlex: W2131641631
Cited by: 342
References: 49
Citations by year: 2026: 6 · 2025: 8 · 2024: 11 · 2023: 4 · 2022: 8 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 9 · 2017: 10 · 2016: 14 · 2015: 12 · 2014: 17 · 2013: 22 · 2012: 22
FWCI: 24.12
Type: journal article
Language: en
Open access: closed
Locations: Brain (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Wellcome Trust
Parkinson's UK (G-4062)
Cotton Research and Development Corporation
Medical Research Council
Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology,University College London
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords: PINK1, Parkinson's disease, sporadic Parkinson's disease, mitochondrial dysfunction, Lewy bodies, mitochondrial localization, neurodegeneration, autosomal recessive parkinsonism, neurofibrillary tangles, alpha-synuclein inclusions, multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, Alzheimer's disease, serine/threonine kinase
MeSH terms: PTEN-Induced Putative Kinase, Alzheimer Disease, Animals, Brain, Carbonates, Female, Heterozygote, Humans, Immunoenzyme Techniques, Male, Middle Aged, Mitochondria, Mutation, Parkinson Disease, Protein Kinases, Submitochondrial Particles, Rats, Wistar, Multiple System Atrophy, Lewy Body Disease, Mitochondrial Membranes, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PINK1 protein in normal human brain and Parkinson's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks